Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5c6d5d7d68-sv6ng Total loading time: 0 Render date: 2024-08-07T02:40:24.870Z Has data issue: false hasContentIssue false

Dictionary

Published online by Cambridge University Press:  03 July 2022

Edited by
Runjan Chetty ,
Kumarasen Cooper ,
Carol Cheung  and
Srinivas Mandavilli
Runjan Chetty
Affiliation:
University of Toronto
Kumarasen Cooper
Affiliation:
University of Pennsylvania
Carol Cheung
Affiliation:
University of Toronto
Srinivas Mandavilli
Affiliation:
Hartford Hospital
Get access
Type
Chapter
Information
Leong's Manual of Diagnostic Biomarkers for Immunohistology , pp. 431 - 462
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Selected references

Anstey, A, Cerio, R, Ramnarain, N, et al. Desmoplastic malignant melanoma: An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16(1):14–22.CrossRefGoogle ScholarPubMed
Daimaru, Y, Hashimoto, H, Enjoji, M. Malignant peripheral nerve sheath tumours (malignant schwannomas):. An immunohistochemical study of 29 cases. Am J Surg Pathol 1985;9:434–44.CrossRefGoogle ScholarPubMed
Loeffel, SC, Gillespie, GY, Mirmiran, SA, et al. Cellular immunolocalisation of S100 protein within fixed tissue sections by monoclonal antibodies. Arch Pathol Lab Med 1985;109:117–22.Google Scholar
Suurmeijer, AJH, Dickson, BC, Swanson, D, et al. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes. Genes Chromosomes Cancer 2018;57(12):611–21.CrossRefGoogle ScholarPubMed

Selected references

Cao, D, Li, J, Guo, CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009;33:1065–77.CrossRefGoogle ScholarPubMed
Cao, D, Guo, S, Allan, RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009;33:894–904.CrossRefGoogle ScholarPubMed
Cao, D, Humphrey, PA, Allan, RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009;115:2640–51.CrossRefGoogle ScholarPubMed
Liu, A, Cheng, L, Du, J, et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol 2010;34:697–706.CrossRefGoogle ScholarPubMed
Miettinen, M, Wang, Z, McCue, PA, et al. SALL4 expression in germ cell and non-germ cell tumors: A systematic immunohistochemical study of 3215 cases. Am J Surg Pathol 2014;38:410–20.Google Scholar
Ushiku, T, Shinozaki, A, Shibahara, J, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 2010;34:533–40.Google Scholar
Wang, F, Liu, A, Peng, Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: An immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol 2009;33:1529–39.CrossRefGoogle ScholarPubMed

Selected references

Agaimy, A, Michal, M, Chiosea, S, et al. Phosphaturic mesenchymal tumors: Clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol 2017;41:1371–80.Google Scholar
Bellizzi, AM. SATB2 in neuroendocrine tumours: Strong expression is restricted to well differentiated tumours of the lower gastrointestinal tract and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Histopathology 2020;76:251–64.Google Scholar
Conner, JR, Hornick, JL. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology 2013;63:36–49.CrossRefGoogle ScholarPubMed
Dragomir, A, de Wit, M, Johansson, C, et al. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study. Am J Clin Pathol 2014:141:630–8.Google Scholar
Geng, G-J, Li, N, Mi, Y-J, et al. Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2015;8:423–31.Google ScholarPubMed
Magnusson, K, de Wit, M, Brennan, DJ, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal cancers. Am J Surg Pathol 2011;35:937–48.Google Scholar
McCluggage, WG, Van der Vijer, K. SATB2 is consistently expressed in squamous morules associated with endometrioid proliferative lesions and in the stroma of atypical polypoid adenomyoma. Int J Gynecol Pathol 2019;38:397–403.Google Scholar

Selected references

Burke, AP, Thomas, RM, Elsayed, AM, et al. Carcinoids of the jejunum and ileum: An immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997;79:1086–93.Google Scholar

Selected references

Baldi, A, Groeger, AM, Esposito, V, et al. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: Relationship with survival. Thorax 2002;57:353–6.Google Scholar
Carbone, M, Rizzo, P, Grimley, PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 1997;3:908–12.CrossRefGoogle ScholarPubMed

Selected references

Agaimy, A, Bertz, S, Cheng, L, et al. Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract. Virchows Arch 2016;469(3):321–30.CrossRefGoogle ScholarPubMed
Conlon, N, Silva, A, Guerra, E, et al. Loss of SMARCA4 expression is both sensitive and specific for the diagnosis of small cell carcinoma of ovary, hypercalcemic type. Am J Surg Pathol 2016;40(3):395–403.CrossRefGoogle ScholarPubMed
Karanian-Philippe, M, Velasco, V, Longy, M, et al. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): A comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas. Am J Surg Pathol 2015;39(9):1197–205.Google Scholar
Kolin, DL, Quick, CM, Dong, F, et al. SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities. Am J Surg Pathol 2020;44(2):263–70.Google Scholar
Perret, R, Chalabreysse, L, Watson, S, et al. SMARCA4-deficient thoracic sarcomas: Clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses. Am J Surg Pathol 2018;43(4):1.Google Scholar

Selected references

Biegel, JA. Molecular genetics of atypical teratoid/rhabdoid tumor. Neurosurg Focus 2006;20:E11.Google Scholar
Bourdeaut, F, Lequin, D, Brugières, L, et al. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011;17:31–8.Google Scholar
Calderaro, J, Moroch, J, Pierron, G, et al. SMARCB1/INI1 inactivation in renal medullary carcinoma. Histopathology 2012;61:428–35.Google Scholar
Hollmann, TJ, Hornick, JL. INI1-deficient tumors: Diagnostic features and molecular genetics. Am J Surg Pathol 2011;35:e47–63.Google Scholar
Hornick, JL, Dal Cin, P, Fletcher, CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.Am J Surg Pathol 2009;33:542–50.Google Scholar
Sullivan, LM, Folpe, AL, Pawel, BR, et al. Mod Pathol 2013;26:385–92. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.Google Scholar

Selected references

Banerjee, SS, Harris, M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000;36:387–402.CrossRefGoogle ScholarPubMed
Kinner, B, Spector, M. Smooth muscle actin expression by human articular chondrocytes and their contraction of a collagen–glycosaminoglycan matrix in vitro. J Orthop Res 2001;19:233–41.Google Scholar
Kung, IT, Thallas, V, Spencer, EJ, et al. Expression of muscle actins in diffuse mesothelioma. Hum Pathol 1995;26:565–70.Google Scholar
Kutzner, H, Mentzel, T, Kaddu, S, et al. Cutaneous myoepithelioma: An under-recognised cutaneous neoplasm composed of myoepithelial cells. Am J Surg Pathol 2001;25:348–55.Google Scholar
Leong, AS-Y, Milios, J, Leong, FJ. Patterns of basal lamina immunostaining in soft-tissue and bony tumors. Appl Immunohistochem 1997;5:1–7.CrossRefGoogle Scholar
Ohta, K, Mortenson, RL, Clark, RA, et al. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Resp Crit Care Med 1995;152:1659–65.Google Scholar
Raymond, WA, Leong, AS-Y. Assessment of invasion in breast lesions using antibodies to basement membrane component and myoepithelial cells. Pathology 1991;23:291–7.Google Scholar
Santini, D, Ceccarelli, C, Leone, O, et al. Smooth muscle differentiation in normal human ovaries, ovarian stromal hyperplasia and ovarian granulosa-stromal cell tumors. Mod Pathol 1995;8:25–30.Google Scholar

Selected references

Borrione, AC, Zanellato, AM, Scannapieco, G, et al. Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur J Biochem 1989;183:413–17.Google Scholar
Eddinger, TJ, Murphy, RA. Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle. Arch Biochem Biophys 1991;284:232–7.Google Scholar
Ioannidis, I, Laurini, JA. Use of smooth muscle myosin heavy chain as an effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol 2019;27(1):48–53.Google Scholar
Savera, AT, Gown, AM, Zarbo, RJ. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: Assessment of the morphogenetic role of myoepithelium. Mod Pathol 1997;10:1093–100.Google ScholarPubMed
Wang, NP, Wan, BC, Skelly, M, et al. Antibodies to novel myoepithelium-associated proteins distinguish benign lesions and carcinoma in situ from invasive carcinoma of the breast. Appl Immunohistochem 1997; 5:141–51.CrossRefGoogle Scholar
White, S, Martin, AG, Periasamy, M. Identification of a novel smooth muscle myosin heavy chain cDNA: Isoform diversity in the SI head region. Am J Physiol 1993;264:1252–8.Google Scholar
Yaziji, H, Gown, AM, Sneige, N. Detection of stromal invasion in breast cancer: The myoepithelial markers. Adv Anat Pathol 2000;7:100–9.Google Scholar

Selected references

Wehrli, BM, Huang, W, De Crombrugghe, B, et al. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 2003;34:3263–9.Google Scholar

Selected references

Behrens, EL, Boothe, W, D’Silva, N, et al. SOX-10 staining in dermal scars. J Cutan Pathol 2019;46(8):579–85.Google Scholar
Cimino-Mathews, A, Subhawong, AP, Elwood, H, et al. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol 2013;44(6):959–65.Google Scholar
Miettinen, M, McCue, PA, Sarlomo-Rikala, M, et al. Sox10–a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: A systematic analysis of 5134 tumors. Am J Surg Pathol 2015;39(6):826–35.CrossRefGoogle ScholarPubMed
Mohamed, A, Gonzalez, RS, Lawson, D, et al. SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol 2013;21(6):506–10.CrossRefGoogle ScholarPubMed
Ohtomo, R, Mori, T, Shibata, S, et al. SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: A clue to the histogenesis for tumor diagnosis. Mod Pathol 2013;26(8):1041–50.Google Scholar
Rooper, LM, Huang, SC, Antonescu, CR, et al. Biphenotypic sinonasal sarcoma: An expanded immunoprofile including consistent nuclear beta-catenin positivity and absence of SOX10 expression. Hum Pathol 2016;55:44–50.Google Scholar

Selected references

Bennett, V. The spectrin-actin junction of erythrocyte membrane skeletons. Biochem Biophys Acta 1989;988:107–22.Google Scholar

Selected references

Demicco, EG, Harms, PW, Patel, RM, et al. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 2015;143(5):672–82.Google Scholar
Doyle, LA, Tao, D, Marino-Enriquez, A. STAT6 is amplified in a subset of dedifferentiated liposarcoma. Mod Pathol 2014;27(9):1231–7.Google Scholar
Doyle, LA, Vivero, M, Fletcher, CD, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 2014;27(3):390–5.Google Scholar
Yoshida, A, Tsuta, K, Ohno, M, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014;38(4):552–9.Google Scholar

Selected references

Braidotti, P, Cigala, C, Graziani, D, et al. Surfactant protein A expression in human normal and neoplastic breast epithelium. Am J Clin Pathol 2001;116:721–8.Google Scholar
Yousem, SA, Wick, MR, Singh, G, et al. So-called sclerosing hemangioma of lung: An immunohistochemical study supporting a respiratory epithelial origin. Am J Surg Pathol 1988;12:582–90.Google Scholar

Selected references

Chejfec, G, Falkmer, S, Grimelius, L, et al. Synaptophysin: A new marker for pancreatic neuroendocrine tumors. Am J Surg Pathol 1987;11:241–7.Google Scholar
Gould, VE, Lee, I, Wiedenmann, B, et al. Synaptophysin: A novel marker for neurons, certain neuroendocrine cells, and their neoplasms. Hum Pathol 1986;17:979–83.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×